QUAKER CHEMICAL CORP·4

May 28, 4:18 PM ET

Bijlani Jeewat 4

4 · QUAKER CHEMICAL CORP · Filed May 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Quaker Chemical EVP Jeewat Exercises Options, Sells 731 Shares

What Happened Bijlani Jeewat, Executive Vice President, Global Specialties & Chief Growth Officer of Quaker Chemical Corporation (KWR), exercised 731 stock options on May 26, 2026 at an exercise price of $136.64 per share (cost $99,884) and immediately sold those 731 shares in the open market for total proceeds of $106,556 (weighted average sale price $145.77). The transaction produced approximately $6,672 in gross proceeds above the exercise cost. The filing shows the option/derivative was disposed in connection with the exercise and sale (cashless exercise).

Key Details

  • Transaction date: May 26, 2026.
  • Exercise: 731 shares at $136.64 each = $99,884 (code M).
  • Sale: 731 shares at weighted average $145.77 each = $106,556 (code S). Sale prices ranged $145.65–$145.88 (footnote F1).
  • Net proceeds: roughly $6,672 (proceeds minus exercise cost), before taxes/fees.
  • Shares owned after transaction: not specified in this Form 4 (information based on the reporting person's Plan Statement as of March 31, 2026 — footnote F2).
  • Vesting note: the option grant vested in three installments in 2021–2023 (footnote F3).
  • Filing timeliness: Form 4 was filed May 28, 2026 for a May 26, 2026 transaction (filed within the typical two-business-day window).

Context This was an options exercise followed by an immediate sale (a common “cashless” exercise), where the exercised shares were sold to cover the exercise cost and any withholding obligations. Such routine option exercises and subsequent sales do not necessarily indicate a change in an insider’s view of the company; purchases are generally viewed as more informative about insider sentiment than sales.

Insider Transaction Report

Form 4
Period: 2026-05-26
Bijlani Jeewat
EVP, Glob. Spec. & CGO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-26$136.64/sh+731$99,8847,479 total
  • Sale

    Common Stock

    [F1]
    2026-05-26$145.77/sh731$106,5566,748 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F3]
    2026-05-267310 total
    Exercise: $136.64Exp: 2027-03-30Common Stock (731 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: By 401(k))
    62
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.65 to $145.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  • [F2]Information based on reporting person's Plan Statement as of March 31, 2026.
  • [F3]The options for this grant vested in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.
Signature
Victoria K. Gehris, Attorney-in-Fact for Jeewat Bijlani|2026-05-28

Documents

1 file
  • 4
    wk-form4_1779999533.xmlPrimary

    FORM 4